Valuation : Vectura Group

Market Cap 1B 866M 812M 741M 1.4B 96.01B 1.4B 9.63B 3.76B 48.47B 3.77B 3.69B 161B P/E 2019
-27.3x
P/E 2020 6.2x
Enterprise Value 930M 802M 752M 686M 1.29B 88.9B 1.3B 8.92B 3.48B 44.88B 3.49B 3.42B 149B EV / Sales 2019
2.8x
EV / Sales 2020 3.49x
Free-Float
-
Yield 2019 *
-
Yield 2020 -
31/10/25 Liquidia Technologies, Inc. Enters into an Exclusive Licensing Agreement with Vectura Limited CI
17/09/24 Molex Asia Holdings Ltd. signed an agreement to acquire Vectura Group plc from Vectura Fertin Pharma, Inc. for £300 million. CI
16/04/24 Mundipharma and Vectura Announce Plans to Reformulate Fluticasone Propionate/Formoterol Fumarate CI
29/12/21 EnBiotix, Inc. announced that it has received $11 million in funding from Vectura Group plc, Cystic Fibrosis Foundation CI
03/12/21 Philip Morris CEO does not need M&A to hit smoke free goals RE
02/12/21 REUTERS NEXT- PHILIP MORRIS CEO ON VECTURA DEAL - THOSE WORRIES THAT PEOPLE WILL LEAVE (BECAUSE OF DEAL) ARE WELL PUT BEHIND US RE
02/12/21 REUTERS NEXT- PHILIP MORRIS CEO SAYS IN INVESTOR CONFERENCE IN FEB WE WILL HAVE QUALITY TIME TO EXPLAIN THE SOLVABLE OPPORTUNITIES TO INVESTORS WHAT VECTURA AND FERTIN WILL BRING TO PMI RE
02/12/21 REUTERS NEXT- PHILIP MORRIS CEO ON VECTURA DEAL - NO SCIENTISTS FROM VECTURA HAVE LEFT CO BECAUSE OF PMI'S ACQUISITION RE
02/12/21 REUTERS NEXT- PHILIP MORRIS CEO ON VECTURA DEAL - "I DON’T THINK THERE IS ANYBODY WHO WILL DISAGREE THAT THIS IS A POSITIVELY DRIVEN TRANSFORMATION" RE
02/12/21 REUTERS NEXT- PHILIP MORRIS CEO SAYS IN INVESTOR CONFERENCE IN FEB WE WILL HAVE QUALITY TIME TO EXPLAIN THE SOLVABLE OPPORTUNITIES TO INVESTORS WHAT VECTURA AND FERTIN WILL BRING TO PMI RE
02/12/21 REUTERS NEXT- PHILIP MORRIS CEO ON VECTURA DEAL - THOSE WORRIES THAT PEOPLE WILL LEAVE (BECAUSE OF DEAL) ARE WELL PUT BEHIND US RE
02/12/21 REUTERS NEXT- PHILIP MORRIS CEO ON VECTURA DEAL - NO SCIENTISTS FROM VECTURA HAVE LEFT CO BECAUSE OF PMI'S ACQUISITION RE
02/12/21 REUTERS NEXT- PHILIP MORRIS CEO ON VECTURA DEAL - "I DON’T THINK THERE IS ANYBODY WHO WILL DISAGREE THAT THIS IS A POSITIVELY DRIVEN TRANSFORMATION" RE
5 years 163.4
Extreme 163.4
170.4
10 years 59.1
Extreme 59.1
180.88
Manager TitleAgeSince
Chief Executive Officer - -
Chief Tech/Sci/R&D Officer - 01/06/2016
Corporate Secretary - 30/06/2025
Director TitleAgeSince
Director/Board Member 53 15/09/2023
Director/Board Member 57 30/06/2025
Date Insider Type Main position Quantity % Market Cap.
10/1/21 A Fiscal year 81,089 0.0133%
10/1/21 A Sell 119,429 0.0196%
10/1/21 A Fiscal year 1,928,114 0.3160%

Financials

2019 2020
Net sales 178M 154M 144M 131M 248M 17.04B 249M 1.71B 667M 8.6B 669M 655M 28.52B 191M 164M 154M 141M 265M 18.22B 266M 1.83B 713M 9.2B 716M 700M 30.49B
Net income -22.1M -19.04M -17.86M -16.3M -30.71M -2.11B -30.8M -212M -82.65M -1.07B -82.97M -81.17M -3.54B 122M 105M 98.89M 90.27M 170M 11.7B 171M 1.17B 458M 5.91B 460M 450M 19.58B
Net Debt -66.5M -57.3M -53.73M -49.05M -92.39M -6.36B -92.69M -637M -249M -3.21B -250M -244M -10.64B -74.4M -64.11M -60.11M -54.87M -103M -7.11B -104M -713M -278M -3.59B -279M -273M -11.9B
Logo Vectura Group
Vectura Group plc is engaged in research, development and commercialization of therapeutic products and drug delivery systems for human use. The Company's products include Ultibro Breezhaler (European Union (EU) and Rest of World (RoW)) - LABA-LAMA; Seebri Breezhaler (EU and RoW) - LAMA; AirFluSal Forspiro (EU and RoW) - ICS-LABA; ADVATE (Global) - Antihaemophilic Factor (Recombinant); Adept (Global) - Icodextrin; Anoro Ellipta (Global) - LAMA-LABA; Relvar Ellipta/Breo Ellipta (Global) - ICS-LABA, and Incruse Ellipta (Global) - LAMA. Its product pipeline includes VR588, VR475, VR647, VR942, VR179, VR736, VR096, VR876, VR315, VR506, VR632, Seebri Neohaler and VR465. Its dry powder inhalers (DPI) include GyroHaler, Lever-operated, Open-inhale-close and Unit Dose DPI. Its smart nebuliser delivery systems provide targeted inhalation therapy for applications where precise and targeted delivery of a drug to the lungs is needed. Its smart nebulizer delivery systems include AKITA JET and FOX.
Employees
-
Sector
-